Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease

por Paka, Latha, Smith, David E, Jung, Dawoon, McCormack, Siobhan, Zhou, Ping, Duan, Bin, Li, Jing-Song, Shi, Jiaqi, Hao, Yong-Jie, Jiang, Kai, Yamin, Michael, Goldberg, Itzhak D, Narayan, Prakash
Publicado 2017